|
Lipids, Lipoproteins, and Cardiovascular Risk Factors
Citations 191-200 of 519 total displayed.
|
Past content
(since Jan 1997):
|
- Lipids, Lipoproteins, and Cardiovascular Risk Factors
Serum Lipid Concentrations and Prevalence of Dyslipidemia in a Large Professional Population in Beijing
- Zhiyan Li, Ruifeng Yang, Guobing Xu, and Tiean Xia
Clin. Chem. 2005; 51: 144-150.
[Abstract]
[Full text]
[PDF]
- General Clinical Chemistry
Response of Homocysteine, Cystathionine, and Methylmalonic Acid to Vitamin Treatment in Dialysis Patients
- Rima Obeid, Martin K. Kuhlmann, Hans Köhler, and Wolfgang Herrmann
Clin. Chem. 2005; 51: 196-201.
[Abstract]
[Full text]
[PDF]
- Technical Briefs
Assay for SjögrenLarsson Syndrome Based on a Deficiency of Phytol Degradation
- Daan M. van den Brink, Joram M. van Miert, and Ronald J.A. Wanders
Clin. Chem. 2005; 51: 240-242.
[Extract]
[Full text]
[PDF]
- Technical Briefs
HPLCTandem Mass Spectrometric Method for Rapid Quantification of Dimethylarginines in Human Plasma
- Hartmut Kirchherr and W. Nikolaus Kühn-Velten
Clin. Chem. 2005; 51: 249-252.
[Extract]
[Full text]
[PDF]
- Technical Briefs
Statin Therapy Has No Significant Effect on Skin Tissue Cholesterol: Results from a Prospective Randomized Trial
- Markus Reiter, Susan Wirth, Ali Pourazim, Mehrdad Baghestanian, Erich Minar, and Robert A. Bucek
Clin. Chem. 2005; 51: 252-254.
[Extract]
[Full text]
[PDF]
- Technical Briefs
Blood Spot Homocysteine: A Feasibility and Stability Study
- Ann Bowron, Anna Barton, Jeff Scott, and David Stansbie
Clin. Chem. 2005; 51: 257-258.
[Extract]
[Full text]
[PDF]
- Case Reports
Liver Dysfunction and Steatosis in Familial Hypobetalipoproteinemia
- Amanda J. Whitfield, P. Hugh R. Barrett, Ken Robertson, Marek F. Havlat, Frank M. van Bockxmeer, and John R. Burnett
Clin. Chem. 2005; 51: 266-269.
[Abstract]
[Full text]
[PDF]
- Editorials
Cardiac Biomarkers in Renal Disease: The Fog Is Slowly Lifting
- Scott J. Cameron and Gary B. Green
Clin. Chem. 2004; 50: 2233-2235.
[Extract]
[Full text]
[PDF]
- Proteomics and Protein Markers
Multi-Biomarker Risk Stratification of N-Terminal Pro-B-Type Natriuretic Peptide, High-Sensitivity C-Reactive Protein, and Cardiac Troponin T and I in End-Stage Renal Disease for All-Cause Death
- Fred S. Apple, MaryAnn M. Murakami, Lesly A. Pearce, and Charles A. Herzog
Clin. Chem. 2004; 50: 2279-2285.
[Abstract]
[Full text]
[PDF]
- Lipids, Lipoproteins, and Cardiovascular Risk Factors
Distribution Spectrum of Paraoxonase Activity in HDL Fractions
- Christoph Bergmeier, Rüdiger Siekmeier, and Werner Gross
Clin. Chem. 2004; 50: 2309-2315.
[Abstract]
[Full text]
[PDF]
|
|